Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan. (Record no. 22383328)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02192 a2200565 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516130046.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201311s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1442-200X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1111/j.1442-200X.2012.03712.x |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kodama, Yoshihiko |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20131126 |
245 00 - TITLE STATEMENT | |
Title | Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Pediatrics international : official journal of the Japan Pediatric Society |
Date of publication, distribution, etc. | Dec 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 923-6 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Inhalation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bosentan |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bronchodilator Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epoprostenol |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fatal Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Follow-Up Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infant, Newborn |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nitric Oxide |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Persistent Fetal Circulation Syndrome |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Piperazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Platelet Aggregation Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pulmonary Alveoli |
General subdivision | abnormalities |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Purines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sildenafil Citrate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vasodilator Agents |
General subdivision | administration & dosage |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tao, Katsuo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ishida, Fumihiko |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kawakami, Tadashi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tsuchiya, Keiji |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ishida, Kazuo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Takemura, Tamiko |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nakazawa, Atsuko |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Matsuoka, Kentaro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yoda, Hitoshi |
773 0# - HOST ITEM ENTRY | |
Title | Pediatrics international : official journal of the Japan Pediatric Society |
Related parts | vol. 54 |
-- | no. 6 |
-- | p. 923-6 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1111/j.1442-200X.2012.03712.x">https://doi.org/10.1111/j.1442-200X.2012.03712.x</a> |
Public note | Available from publisher's website |
No items available.